About: Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management
Creator	Anwar, C Chahal, A Cooper, Leslie Deo, Rajat Khanji, Mohammed Muser, Daniele Nazarian, Saman Santangeli, Pasquale Siripanthong, Bhurint
source	Elsevier; Medline; PMC
abstract	Human coronavirus-associated myocarditis is known, and a number of COVID-19-related myocarditis cases have been reported. The pathophysiology of COVID-19-related myocarditis is thought to be a combination of direct viral injury and cardiac damage due to the host’s immune response. COVID-19 myocarditis diagnosis should be guided by insights from previous coronavirus and other myocarditis experience. The clinical findings include changes in ECG, cardiac biomarkers, and impaired cardiac function. When cardiac MRI is infeasible, cardiac CT angiography with delayed myocardial imaging may serve to exclude significant coronary artery disease and identify myocardial inflammatory patterns. Because many COVID-19 patients have cardiovascular comorbidities, myocardial infarction should be considered. Where the diagnosis remains uncertain, an endomyocardial biopsy may help identify active cardiac infection through viral genome amplification and possibly refine the treatment risks of systemic immunosuppression. Arrhythmias are not uncommon in the COVID-19 patients; however, its pathophysiology is still speculative. Nevertheless, clinicians should be vigilant to provide prompt monitoring and treatments. The long-term impact of COVID-19 myocarditis, including in the majority of mild cases remains unknown.
has issue date	2020-05-05(xsd:dateTime)
bibo:doi	10.1016/j.hrthm.2020.05.001
bibo:pmid	32387246
has license	no-cc
sha1sum (hex)	83284b9347ee9b89e6a621525740b95e443c10ee
schema:url	https://doi.org/10.1016/j.hrthm.2020.05.001
resource representing a document's title	Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management
has PubMed Central identifier	PMC7199677
has PubMed identifier	32387246
schema:publication	Heart Rhythm
resource representing a document's body	covid:83284b9347ee9b89e6a621525740b95e443c10ee#body_text
is schema:about of	named entity 'myocarditis' named entity 'ventricular assist device' named entity 'cell adherence' named entity 'coronary angiography' named entity 'infection' named entity 'ACE2' named entity 'arrhythmia' named entity 'immune cells' named entity 'HGF receptor' named entity 'case report' named entity 'SARS-CoV-2' named entity 'cardiomyopathies' named entity 'coronaviruses' named entity 'SARS-CoV-2' named entity 'arrhythmias' named entity 'tachycardia' named entity 'T-lymphocytes' named entity 'medical treatment' named entity 'clinical testing' named entity 'arrhythmia' named entity 'cardiogenic shock' named entity 'COVID-19' named entity 'COVID' named entity 'fulminant' named entity 'desmosomal' named entity 'Angiotensin-Converting Enzyme 2' named entity 'organ dysfunction' named entity 'etiology' named entity 'sample size' named entity 'arrhythmias' named entity 'myocarditis' named entity 'SARS-CoV-2' named entity 'sinus tachycardia' named entity 'COVID-19' named entity 'acute respiratory distress syndrome' named entity 'heart failure' named entity 'viruses' named entity 'myocarditis' named entity 'protein' named entity 'randomized-controlled trial' named entity 'desmosomal' named entity 'cytokine' named entity 'SARS-CoV-2' named entity 'upregulated' named entity 'myocarditis' named entity 'lower respiratory tract' named entity 'ventricular dysfunction' named entity 'T-lymphocytes' named entity 'myocarditis' named entity 'myocarditis' named entity 'flu-like symptoms' named entity 'myocarditis' named entity 'heart failure' named entity 'IL-6' named entity 'arrhythmogenic' named entity 'COVID-19' named entity 'SARS-CoV-2' named entity 'cardiac imaging' named entity 'Interleukin-6' named entity 'Takotsubo cardiomyopathy' named entity 'Pathology' named entity 'QTc interval prolongation' named entity 'spike protein' named entity 'ventricular arrhythmias' named entity 'sepsis' named entity 'COVID-19' named entity 'HGF' named entity 'cardiovascular risk factors' named entity 'cardiomyocytes' named entity 'medical attention' named entity 'enzyme' named entity 'electrolyte imbalance' named entity 'heart failure'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software